Second malignancies following conventional or combined (252)Cf neutron brachytherapy with external beam radiotherapy for breast cancer

We retrospectively evaluated the risk of second malignancies among 832 patients with inner or central breast cancer treated with conventional external beam schedule (CRT group), or neutron brachytherapy using Californium-252 ((252)Cf) sources and hypofractionated external beam radiotherapy (HRTC gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Valuckas, Konstantinas Povilas, Atkocius, Vydmantas, Kuzmickiene, Irena, Aleknavicius, Eduardas, Liukpetryte, Sarune, Ostapenko, Valerijus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766283/
https://www.ncbi.nlm.nih.gov/pubmed/23397075
http://dx.doi.org/10.1093/jrr/rrt009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766283/
https://www.ncbi.nlm.nih.gov/pubmed/23397075
http://dx.doi.org/10.1093/jrr/rrt009

Ejemplares similares